Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 122-129 , November 2006

Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: The need for a multivariate approach in biomarker studies

  • Ala Yaromina

      Affiliations

    • Department of Radiation Oncology
    • ,
  • Daniel Zips

      Affiliations

    • Department of Radiation Oncology
    • ,
  • Howard D. Thames

      Affiliations

    • Department of Biostatistics and Applied Mathematics, University of Texas M.D. Anderson Cancer Centre, Houston, TX, USA
    • ,
  • Wolfgang Eicheler

      Affiliations

    • Department of Radiation Oncology
    • Experimental Centre, and
    • ,
  • Mechthild Krause

      Affiliations

    • Department of Radiation Oncology
    • ,
  • Andrea Rosner

      Affiliations

    • Department of Radiation Oncology
    • ,
  • Michael Haase

      Affiliations

    • OncoRay – Centre for Radiation Research in Oncology, Medical Faculty Carl Gustav Carus, University of Technology Dresden, Germany
    • ,
  • Cordula Petersen

      Affiliations

    • Department of Radiation Oncology
    • ,
  • James A. Raleigh

      Affiliations

    • Department of Radiation Oncology, Chapel Hill, NC, USA
    • ,
  • Verena Quennet

      Affiliations

    • Institute of Physiology and Pathophysiology, University of Mainz, Germany
    • ,
  • Stefan Walenta

      Affiliations

    • Institute of Physiology and Pathophysiology, University of Mainz, Germany
    • ,
  • Wolfgang Mueller-Klieser

      Affiliations

    • Institute of Physiology and Pathophysiology, University of Mainz, Germany
    • ,
  • Michael Baumann

      Affiliations

    • Department of Radiation Oncology
    • Experimental Centre, and
    • OncoRay – Centre for Radiation Research in Oncology, Medical Faculty Carl Gustav Carus, University of Technology Dresden, Germany
    • Corresponding Author InformationCorresponding author. Michael Baumann, Department of Radiation Oncology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.

Received 18 April 2006 ,Revised 24 July 2006 ,Accepted 11 August 2006.

References 

  1. Arteel GE, Thurman RG, Yates JM, Raleigh JA. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer. 1995;72:889–895
  2. Baumann M, Pu A, Dubois W. Quantitative evaluation of the effects of cotransplantation of heavily irradiated human tumor cells and of different immunosuppressive measures on the xenotransplantability of a human squamous cell carcinoma into athymic nude mice. In:  Fiebig HH,  Berger DP editor. Immunodeficient mice in oncology. Karger: Wiley; 1992;p. 98–107
  3. Bentzen SM, Tucker SL. Quantifying the position and steepness of radiation dose–response curves. Int J Radiat Biol. 1997;71:531–542
  4. Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol. 1984;23:379–391
  5. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997;38:285–289
  6. Broders AC. Carcinoma of the mouth: types and degrees of malignancy. Am J Roentgenol Red Ther Nucl Med. 1927;17:90–93
  7. Brown JM. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol. 1979;52:650–656
  8. Bussink J, Kaanders JH, van der Kogel AJ. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol. 2003;67:3–15
  9. Efron B, Tibshirani R. Bootstrap measures for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1:54–77
  10. Eicheler W, Krause M, Hessel F, Zips D, Baumann M. Kinetics of EGFR expression during fractionated irradiation varies between different human squamous cell carcinoma lines in nude mice. Radiother Oncol. 2005;76:151–156
  11. Fyles A, Milosevic M, Hedley D, et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol. 2002;20:680–687
  12. Gross MW, Karbach U, Groebe K, Franko AJ, Mueller-Klieser W. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int J Cancer. 1995;61:567–573
  13. Hessel F, Krause M, Helm A, et al. Differentiation status of human squamous cell carcinoma xenografts does not appear to correlate with the repopulation capacity of clonogenic tumour cells during fractionated irradiation. Int J Radiat Biol. 2004;80:719–727
  14. Höckel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56:4509–4515
  15. Kaanders JH, Wijffels KI, Marres HA, et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res. 2002;62:7066–7074
  16. Kleiter MM, Thrall DE, Malarkey DE, et al. A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker. Int J Radiat Oncol Biol Phys. 2006;64:592–602
  17. Krause M, Hessel F, Zips D, Hilberg F, Baumann M. Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinoma. Radiother Oncol. 2004;72:95–101
  18. Krause M, Ostermann G, Petersen C, et al. Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation. Radiother Oncol. 2005;76:162–167
  19. Krause M, Schutze C, Petersen C, et al. Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC. Radiother Oncol. 2005;74:109–115
  20. Nordsmark M, Bentzen SM, Rudat V, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol. 2005;77:18–24
  21. Nordsmark M, Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol. 2000;57:39–43
  22. Overgaard J, Eriksen JG, Nordsmark M, Alsner J, Horsman MR. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. Lancet Oncol. 2005;6:757–764
  23. Petersen C, Zips D, Krause M, et al. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation. Int J Radiat Oncol Biol Phys. 2001;51:483–493
  24. Petersen C, Zips D, Krause M, Volkel W, Thames HD, Baumann M. Recovery from sublethal damage during fractionated irradiation of human FaDu SCC. Radiother Oncol. 2005;74:331–336
  25. Steel GG. Cell survival as a determinant of tumour response. In:  Steel GG editors. Basic clinical radiobiology. 3rd ed.. London: Arnold; 2002;p. 52–63
  26. Steel GG. The oxygen effect and tumour microenvironment. In:  Steel GG editors. Basic clinical radiobilogy. 3rd ed.. London: Arnold; 2002;p. 158–168
  27. Vordermark D, Menke DR, Brown JM. Similar radiation sensitivities of acutely and chronically hypoxic cells in HT 1080 fibrosarcoma xenografts. Radiat Res. 2003;159:94–101
  28. Walenta S, Wetterling M, Lehrke M, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60:916–921
  29. Walker AM, Suit HD. Assessment of local tumor control using censored tumor response data. Int J Radiat Oncol Biol Phys. 1983;9:383–386
  30. Withers HR. The four R’s of radiotherapy. Adv Radiat Biol. 1975;5:241–247
  31. Wouters BG, Brown JM. Cells at intermediate oxygen levels can be more important than the “hypoxic fraction” in determining tumor response to fractionated radiotherapy. Radiat Res. 1997;147:541–550
  32. Yaromina A, Holscher T, Eicheler W, et al. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?. Radiother Oncol. 2005;76:206–212
  33. Zietman AL, Suit HD, Ramsay JR, Silobrcic V, Sedlacek RS. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice. Cancer Res. 1988;48:6510–6516
  34. Zips D, Adam M, Flentje M, et al. Impact of hypoxia and the metabolic microenvironment on radiotherapy of solid tumors. Introduction of a multi-institutional research project. Strahlenther Onkol. 2004;180:609–615

PII: S0167-8140(06)00375-6

doi: 10.1016/j.radonc.2006.08.010

Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 122-129 , November 2006

Article Tools

* Image Usage & Resolution